Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/INNOVATION-PHARMACEUTICAL-111313705/news/Cellceutix-Completes-Enrollment-in-Second-of-Three-Planned-Cohorts-in-Phase-2-Clinical-Trial-of-Bril-23706679/?utm_source=whatsapp&utm_medium=social&utm_campaign=share